可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]李妮妮,廉哲勋,葛毅萍,等. 缺血后处理和三磷酸腺苷后处理对心肌缺血再灌注损伤的影响[J].中华老年心脑血管病杂志,2010,12(3):50-53.
[2]刘 方,廉哲勋,王永彬,等. 缺血后处理、ATP后处理减轻兔缺血再灌注损伤:与腺苷受体激活有关[J].现代生物医学进展,2007, 7(3):353-355.
[3]Zhao ZQ,Corvera JS,Halkos ME,et al.Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning[J].Am J Physiol Heart Circ Physiol,2003,285(2):H579-H588.
[4]Staat P,Rioufol G,Piot C,et al.Postconditioning the human heart[J].Circulation,2005, 112(14):2143-2148.
[5]司良毅,彭念寅,陈运贞.心肌缺血再灌注损伤与白细胞介素-1表达水平的相关性研究[J].中国临床康复,2004,8(18):3666-3668.
[6]Souza DG,Guabiraba R,Pinho V,et al.IL-1-driven endogenous IL-10 production protects against the systemic and local acute inflammatory response following intestinal reperfusion injury[J].J Immunol,2003,170(9):4759-4766.
[7]杨 简,杨 俊,丁家望,等.腺苷介导大鼠心脏缺血后适应的保护效应[J].中华老年心脑血管病杂志,2008,10(4):293-295.
[8]沈 诚,范士志,陈建明,等.JAK/STAT通路对缺血再灌注心肌NF-κB和TNF-α表达的影响[J].中国现代医学杂志,2006,16(7):985-987,991.
[9]Barry SP,Townsend PA,Latchman DS,et al.Role of the JAK-STAT pathway in myocardial injury[J].Trends Mol Med,2007,13(2):82-89.